0.41
-0.1329(-24.69%)
Currency In USD
Address
13576 Walnut Street
Omaha, NE 68144
United States of America
Phone
833 931 6330
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
April 29, 2022
| Name | Title | Pay | Year Born |
| Joseph Sinkule | Founder, Chief Executive Officer, Chairman of the Board & Secretary | 480,000 | 1954 |
| Shalom Z. Hirschman | Medical Advisor & Director | 120,000 | 1936 |
| Peter J. Moriarty | Chief Business Officer | 172,500 | 1950 |
| Jeffrey LeBlanc | Chief Financial Officer | 401,506 | 1973 |
| Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant | 0 | 1966 |
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
